AC

AIGH Capital Management

North America, Maryland, United States, Baltimore

Description

AIGH Capital Management is a private equity firm

Investor Profile

AIGH Capital Management has made 3 investments, with 1 in the past 12 months and 67% as lead.

Stage Focus

  • Post Ipo Equity (67%)
  • Undisclosed (33%)

Country Focus

  • United States (67%)
  • Israel (33%)

Industry Focus

  • Medical
  • Medical Device
  • Biotechnology
  • Therapeutics
  • Dental
  • Health Care
  • Product Design
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AIGH Capital Management frequently co-invest with?

Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 1
Second Line
North America, Louisiana, United States, New Orleans
Co-Investments: 1
AP
North America, California, United States, Belmont
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by AIGH Capital Management?

Plus Therapeutics

Austin, Texas, United States

Plus Therapeutics is a clinical-stage pharmaceutical company that develops targeted therapies to treat cancer and other serious diseases.

BiotechnologyMedicalPharmaceuticalTherapeutics
Post Ipo EquityMay 6, 2024
Amount Raised: $6,500,000
Cellectar Biosciences

Madison, Wisconsin, United States

Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.

BiotechnologyMedical DeviceTherapeutics
Post Ipo EquitySep 5, 2023
Amount Raised: $103,000,000
Dror Ortho-Design

Jerusalem, Yerushalayim, Israel

Dror Ortho-Design develops an innovative AI-driven platform for painless and minimally invasive smile correction.

DentalHealth CareMedicalMedical DeviceProduct Design
UndisclosedJul 6, 2023
Amount Raised: $5,500,000